A field trial to assess a blood-stage malaria vaccine (Q35622737)

9 August 2017

A field trial to assess a blood-stage malaria vaccine (English)

1 reference

9 August 2017

0 references

1 reference

1 reference

14

Amagana Dolo

0 references

Shannon Takala-Harrison

19

Shannon Takala-Harrison

0 references

Matthew Laurens

Matthew B Laurens

4

0 references

Mahamadou A. Thera

Mahamadou A Thera

1

0 references

Ogobara K. Doumbo

2

Ogobara K Doumbo

1 reference

9 August 2017

36

Christopher V Plowe

1 reference

9 August 2017

3

Drissa Coulibaly

1 reference

9 August 2017

16

Mahamadou S Sissoko

1 reference

9 August 2017

11

Dapa A Diallo

1 reference

9 August 2017

17

Amadou Niangaly

1 reference

9 August 2017

26

W Ripley Ballou

1 reference

9 August 2017

20

Kirsten E Lyke

1 reference

9 August 2017

24

Johan Vekemans

1 reference

9 August 2017

25

Marie-Claude Dubois

1 reference

9 August 2017

35

D Gray Heppner

1 reference

9 August 2017

10

Bourema Kouriba

1 reference

9 August 2017

5

Amed Ouattara

1 reference

9 August 2017

6

Abdoulaye K Kone

1 reference

9 August 2017

12

Issa Diarra

1 reference

9 August 2017

30

Lorraine Soisson

1 reference

9 August 2017

31

Carter L Diggs

1 reference

9 August 2017

34

Sheetij Dutta

1 reference

9 August 2017

13

Modibo Daou

1 reference

9 August 2017

8

Karim Traore

1 reference

9 August 2017

15

Youssouf Tolo

1 reference

9 August 2017

7

Ando B Guindo

1 reference

9 August 2017

23

Olivier Godeaux

1 reference

9 August 2017

33

David E Lanar

1 reference

9 August 2017

22

William C Blackwelder

1 reference

9 August 2017

Idrissa Traore

9

1 reference

9 August 2017

Mady Sissoko

18

1 reference

9 August 2017

Yukun Wu

21

1 reference

9 August 2017

Joe Cohen

27

1 reference

9 August 2017

Darby Thompson

28

1 reference

9 August 2017

Tina Dube

29

1 reference

9 August 2017

Brent House

32

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 September 2011

1 reference

The New England Journal of Medicine

9 August 2017

1 reference

9 August 2017

365

1 reference

9 August 2017

11

1 reference

9 August 2017

1004-1013

1 reference

A research agenda for malaria eradication: vaccines

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

Cell-mediated immunity elicited by the blood stage malaria vaccine apical membrane antigen 1 in Malian adults: results of a Phase I randomized trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

Structural basis of antigenic escape of a malaria vaccine candidate

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242358

25 September 2018

Identifiers

DOI

10.1056/NEJMOA1008115

1 reference

9 August 2017

1 reference

9 August 2017

1 reference